PFE Stock Chart & Fundamental Analysis

Interactive Chart

About Pfizer, Inc.

Name

Pfizer, Inc.

CEO

Albert Bourla

Website

www.pfizer.com

Industry

Healthcare

Year Founded

1849

Employees

81,000

Pfizer Inc. develops, makes, and sells prescription medicines and vaccines worldwide. Listed on the NYSE as PFE, the company operates in the pharmaceutical business and generated $62.6 billion of revenue in FY2025. Its portfolio spans branded therapies, biosimilars, hospital injectables, and vaccines used across a wide range of treatment and prevention settings.

Analyst Ratings

Consensus Recommendation

Buy1

Hold1

Sell5

Fundamentals & Financials

Revenue (TTM)

$63.3B

Net Income (TTM)

$7.4B

EPS (TTM)

$1.31

ROA (TTM)

3.61%

Current Ratio

1.25

Dividend Yield

1.55%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Item	Q1 FY2026	Q4 FY2025	Q3 FY2025
Revenue	$14,451M	$17,557M	$16,654M
Cost of Sales	$4,731M	$5,272M	$4,172M
Gross Profit	$9,720M	$12,285M	$12,482M
Operating Income	$4,032M	$3,688M	$3,550M
Net Income	$2,688M	-$1,648M	$3,541M
EPS	$0.47	-$0.29	$0.62

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings Calendar

Technical Indicators

Pfizer, Inc.'s Technical Indicators Summary

PFE appears as a strong sell driven by broad weakness across moving averages, negative momentum and declining volume, with MACD and momentum both tilting bearish and the ADX signaling trend pressure. The price is below most key averages including the 200-day, while ATR remains subdued and the pivot sits slightly lower but offers limited support. Taken together, the technical picture points to persistent downside pressure. Technical takeaway: Strong Sell.

Buy

1 signal

Neutral

1 signal

Sell

5 signals

Overall: Bearish71% Bearish signals

Indicator	Value	Signal	Explanation
ATR (14)	$0.58 (2.37%)	Neutral	Moderate Volatility (2.37%).
RSI (14)	39.78	Neutral	RSI (39.78) is neutral.
Stochastic %K (14, 3, 3)	16.49	Buy	Stochastic (16.49) < 20, indicating oversold.
CCI (20)	-74.33	Neutral	CCI (-74.33) is neutral.
WPR (14)	-75.61	Neutral	Williams %R (-75.61) is neutral.
Momentum (10)	-1.60	Sell	Momentum (-1.60) is negative.
MFI	29.30	Neutral	MFI (29.30) is neutral.
MACD Level (12, 26)	-0.52	Sell	Confirmed downtrend: MACD (-0.52) is negative and below its signal line (-0.42).
Bollinger Bands	$23.39 - $26.88	Neutral	Price is within the bands.
ADX (14)	25.03	Sell	Strong downtrend (ADX > 25) with bearish directional movement. ADX(25.03), +DI(14.67), -DI(28.38)
OBV	82,820,583	Sell	Bearish volume pressure: OBV is below its 20-day SMA. OBV(82,820,583), 20D-SMA-OBV(261,595,594)
Classic Pivot Point	$23.95	Buy	Price ($24.32) has broken above resistance R1 ($24.17) — bullish breakout potential.
Fibonacci Pivot Point	$23.95	Buy	Price ($24.32) has broken above resistance R1 ($24.14) — bullish breakout potential.
Exponential Moving Averages	$24.46 - $25.91(5 indicators)	Sell	EMA group: 5/5 bearish, 0 bullish, 0 neutral. Price below key EMA averages.
Simple Moving Averages	$24.37 - $26.48(5 indicators)	Sell	SMA group: 5/5 bearish, 0 bullish, 0 neutral. Price below key SMA averages.

Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

By the close, PFE held onto a small 1.80% gain versus yesterday. Into the close, PFE still showed subdued interest, with volume at 0.69× its norm. PFE edges higher on news of Pfizer's updated Comirnaty fall booster, while trading with lighter-than-average volume.

Trading Volume

vs S&P 500 Today

Outperforming Market

+0.76%

52-Week Position

Lower range

21.3%

Updated: July 2, 2026 at 20:09 UTC